Miroslav Harjacek
Overview
Explore the profile of Miroslav Harjacek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehair A, Harjacek M
Cureus
. 2025 Jan;
16(12):e75137.
PMID: 39759739
There are several types of inflammatory myopathies, including juvenile dermatomyositis (JDM), which is characterized by muscle inflammation that can eventually lead to weakness. A devastating complication of JDM is macrophage...
2.
Harjacek M
Curr Pediatr Rev
. 2023 Aug;
20(3):323-338.
PMID: 37526457
Limping refers to an asymmetrical gait that deviates from the typical gait pattern expected for a child of a certain age. In most children, limping is caused by a mild,...
3.
Lamot M, Miler M, Nikolac Gabaj N, Lamot L, Milosevic M, Harjacek M, et al.
Front Pediatr
. 2022 Apr;
10:768260.
PMID: 35359908
Background: Febrile illnesses in young children can be a major diagnostic challenge, despite the routine use of various laboratory markers. Recent advancements in the understanding of inflammatory processes have highlighted...
4.
Harjacek M, Joos R, Vargas R
Front Med (Lausanne)
. 2022 Mar;
9:861512.
PMID: 35345764
No abstract available.
5.
Vrsalovic R, Korosec P, Mihatov Stefanovic I, Bidovec-Stojkovic U, cicak B, Harjacek M, et al.
Respir Med
. 2022 Feb;
193:106757.
PMID: 35123356
Background: Thymic stromal lymphopoietin (TSLP), an epithelium-derived pro-inflammatory cytokine, activates distinct immune and non-immune cells. It has been shown to be a master regulator of type 2 immune responses. Limited...
6.
Harjacek M
Front Med (Lausanne)
. 2021 Oct;
8:700982.
PMID: 34692718
Juvenile spondyloarthritis (jSpA) is a an umbrella term for heterogeneous group of related seronegative inflammatory disorders sharing common symptoms. Although it mainly affects children and adolescents, it often remains active...
7.
Lamot L, Miler M, Vukojevic R, Vidovic M, Lamot M, Trutin I, et al.
Front Med (Lausanne)
. 2021 Mar;
8:650619.
PMID: 33763437
Enthesitis related arthritis (ERA) is a specific subtype of juvenile idiopathic arthritis (JIA), often regarded as an undifferentiated form of juvenile spondyloarthritis (jSpA). While gut is increasingly recognized as origin...
8.
Vukic V, Smajo A, Vidovic M, Vukojevic R, Harjacek M, Lamot L
BMC Pediatr
. 2021 Jan;
21(1):40.
PMID: 33451288
Background: The last two decades brought new treatment options and high quality guidelines into the paediatric rheumatologic practice. Nevertheless, a number of patients still present a diagnostic and therapeutic challenge...
9.
Giancane G, Campone C, Gicchino M, Alongi A, Bava C, Rosina S, et al.
Arthritis Care Res (Hoboken)
. 2020 Nov;
73(12):1722-1729.
PMID: 33242352
Objective: To assess concordance among criteria for inactive disease (ID) and low disease activity (LDA) in juvenile idiopathic arthritis (JIA) and to seek factors driving discordance. Methods: The frequency of...
10.
Nordal E, Pistorio A, Rygg M, Giancane G, Maghnie M, Di Iorgi N, et al.
Arthritis Care Res (Hoboken)
. 2019 Sep;
72(2):265-273.
PMID: 31507092
Objective: To study growth and puberty in a multinational longitudinal prospective cohort of children with juvenile dermatomyositis (DM). Methods: Children from 31 countries who were ages <18 years and had...